Connect with us

Biochemistry

Revolutionizing Gene Delivery with ENVLPE: A Breakthrough in Precision Medicine

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than before. Their technology, ENVLPE, uses engineered non-infectious virus-like particles to precisely correct defective genes — demonstrated successfully in living mouse models that are blind due to a mutation. This system also holds promise for advancing cancer therapy by enabling precise genetic manipulation of engineered immune cells making them more universally compatible and thus more accessible for a larger group of cancer patients.

Avatar photo

Published

on

Here is the rewritten article:

Revolutionizing Gene Delivery with ENVLPE: A Breakthrough in Precision Medicine

Genome editing techniques have shown tremendous potential for treating genetic diseases, but delivering these molecular tools reliably to their target cells remains a significant challenge. Previous viral and non-viral delivery systems, such as adeno-associated viruses (AAVs) and lipid nanoparticles (LNPs), have limitations that hinder their effectiveness.

ENVLPE, short for “Engineered Nucleocytosolic Vehicles for Loading of Programmable Editors,” is a revolutionary delivery system designed to overcome these challenges. Led by Dr. Dong-Jiunn Jeffery Truong from the Institute for Synthetic Biomedicine at Helmholtz Munich, the research team developed ENVLPE as a non-infectious virus-like particle that can efficiently transport gene-editing tools into target cells.

“ENVLPE solves two major limitations of earlier systems,” explains Dr. Truong. “Firstly, it ensures the packaging of fully assembled gene editors, which reduces delivery effectiveness in previous methods. Secondly, it contains an extra molecular shield that protects the most vulnerable part of the editor from degradation during transport.”

In a groundbreaking study published in a leading scientific journal, the researchers tested ENVLPE in a mouse model of inherited blindness. The mice carried a disabling mutation in the Rpe65 gene, which is essential for producing light-sensitive molecules in the retina. After injecting ENVLPE into the subretinal space to correct the mutation, the animals began to respond to light stimuli again.

“The extent of restoration was astounding,” says Julian Geilenkeuser, co-first author and a doctoral researcher at the Institute for Synthetic Biomedicine. “It showed us that our particles have real therapeutic potential in a living animal.”

Compared to established systems, ENVLPE achieved significantly better results: a competing system required more than 10 times the dose to reach similar effects.

“Our goal was to build a tool that is both useful for researchers and suitable for real-world applications,” says Niklas Armbrust, also co-first author and a doctoral researcher at the Institute for Synthetic Biomedicine. “We resolved critical bottlenecks and achieved a much more efficient packaging by the delivery agents.”

ENVLPE could also open up new possibilities for adoptive T cell therapies, where immune cells taken from the patient are genetically modified in the lab so that they can specifically recognize and attack tumor cells.

These innovations address critical challenges in both in vivo gene therapies for genetically inherited diseases and ex vivo cell therapies for cancer, paving the way for important translational advancements.

“The highly modular ENVLPE system brings us substantially closer to on-demand and precise genetic modifications of complex cellular models,” says Prof. Gil Westmeyer, Director of the Institute for Synthetic Biomedicine and Professor for Neurobiological Engineering at TUM and co-senior author of the study. “It is an example of how synthetic biology can help drive medical innovation.”

The research team now seeks to use the diversity found in nature, along with recent advancements in AI-assisted protein design, to increase targeting precision by restricting the delivery of these tools to specific cell or tissue types only.

To move ENVLPE toward clinical application, the researchers are pursuing follow-up funding from translational grants and partnerships in the pharmaceutical industry. The goal is to optimize the technology for various therapeutic applications and ultimately make it available to patients.

Batteries

“Unlocking the Secrets of Influenza Viruses: How Scientists Are Studying the Interaction between Viruses and Host Cells”

Influenza viruses are among the most likely triggers of future pandemics. A research team has developed a method that can be used to study the interaction of viruses with host cells in unprecedented detail. With the help of their new development, they have also analyzed how novel influenza viruses use alternative receptors to enter target cells.

Avatar photo

Published

on

The threat of future pandemics has been heightened by the emergence of new influenza viruses. In recent years, researchers from the Helmholtz Centre for Infection Research (HZI) and the Medical Center — University of Freiburg have made significant progress in understanding how these viruses interact with host cells.

Led by Professor Christian Sieben’s team at HZI, scientists have developed a novel method to study the initial contact between influenza viruses and host cells. This breakthrough allows researchers to investigate the complex process of viral entry in unprecedented detail.

The researchers immobilized individual viruses on microscopy glass surfaces and then seeded cells on top. This innovative “upside-down” experimental setup enables scientists to analyze the critical moment when viruses interact with cells but do not enter them, stabilizing the initial cell contact for further investigation.

Using high-resolution and super-resolution microscopy, the team demonstrated that contact between the virus and the cell surface triggers a cascade of cellular reactions. The accumulation of local receptors at the binding site, the recruitment of specific proteins, and the dynamic reorganization of the actin cytoskeleton are just some of the processes observed in this study.

What’s more remarkable is that researchers applied their method not only to an established influenza A model but also to a novel strain found in bats. The H18N11 virus, which targets MHC class II complexes rather than glycans on the cell surface, was shown to cluster specific MHCII molecules upon contact with the cell.

This groundbreaking research has significant implications for understanding alternative receptors used by new and emerging influenza viruses. The findings provide a critical basis for investigating potential pandemic pathogens in a more targeted manner, identifying new targets for antiviral therapies, and ultimately developing effective treatments against future pandemics.

The EU project COMBINE, launched in 2025 and coordinated by Professor Sieben’s team at HZI, aims to investigate the virus entry process of newly emerging viruses. This research has far-reaching implications for understanding and combating infectious diseases, making it a significant contribution to the global fight against pandemics.

Continue Reading

Biochemistry

A Breakthrough in Brain Research: The Iontronic Pipette Revolutionizes Neurological Studies

Researchers have developed a new type of pipette that can deliver ions to individual neurons without affecting the sensitive extracellular milieu. Controlling the concentration of different ions can provide important insights into how individual brain cells are affected, and how cells work together. The pipette could also be used for treatments.

Avatar photo

Published

on

The development of an iontronic pipette at Linköping University has opened up new avenues for neurological research. This innovative tool allows researchers to deliver ions directly to individual neurons without affecting the surrounding extracellular milieu. By controlling the concentration of various ions, scientists can gain valuable insights into how brain cells respond to different stimuli and interact with each other.

The human brain consists of approximately 85-100 billion neurons, supported by a similar number of glial cells that provide essential functions such as nutrition, oxygenation, and healing. The extracellular milieu, a fluid-filled space between the cells, plays a crucial role in maintaining cell function. Changes in ion concentration within this environment can activate or inhibit neuronal activity, making it essential to study how local changes affect individual brain cells.

Previous attempts to manipulate the extracellular environment involved pumping liquid into the area, disrupting the delicate biochemical balance and making it difficult to determine whether the substances themselves or the changed pressure were responsible for the observed effects. To overcome this challenge, researchers at the Laboratory of Organic Electronics developed an iontronic micropipette measuring only 2 micrometers in diameter.

This tiny pipette can deliver ions such as potassium and sodium directly into the extracellular milieu, allowing scientists to study how individual neurons respond to these changes. Glial cell activity is also monitored, providing a more comprehensive understanding of brain function.

Theresia Arbring Sjöström, an assistant professor at LOE, highlighted that glial cells are critical components of the brain’s chemical environment and can be precisely activated using this technology. In experiments conducted on mouse hippocampus tissue slices, it was observed that neurons responded dynamically to changes in ion concentration only after glial cell activity had saturated.

This research has significant implications for neurological disease treatment. The iontronic pipette could potentially be used to develop extremely precise treatments for conditions such as epilepsy, where brain function can be disrupted by localized imbalances in ion concentrations.

Researchers are now continuing their studies on chemical signaling in healthy and diseased brain tissue using the iontronic pipette. They also aim to adapt this technology to deliver medical drugs directly to affected areas of the brain, paving the way for more targeted treatments for neurological disorders.

Continue Reading

Biochemistry

Unraveling Nature’s Secret: How Velvet Worm Slime Could Revolutionize Sustainable Materials Design

A new discovery about the slime ejected by velvet worms could revolutionize sustainable material design. The findings outline how a naturally occurring protein structure, conserved across species from Australia, Singapore and Barbados over nearly 400 million years of evolution, enables the slime’s transformation from liquid to fiber and back again. It’s a discovery that could inspire next-generation recyclable bioplastics.

Avatar photo

Published

on

The discovery of the remarkable properties of velvet worm slime has sent shockwaves through the scientific community, offering new hope for sustainable material design. Researchers from McGill University have made a groundbreaking find that could lead to the development of next-generation recyclable bioplastics.

Velvet worms, small caterpillar-like creatures found in humid forests of the southern hemisphere, possess an extraordinary ability – their slime can transform from liquid to fibre and back again. This remarkable property has puzzled scientists for centuries, but a team led by Matthew Harrington, a chemistry professor and Canada Research Chair in green chemistry, has finally decoded the molecular structure behind this phenomenon.

Using protein sequencing and AI-driven structure prediction (AlphaFold), the researchers identified previously unknown proteins in the slime that function similarly to cell receptors in the immune system. These receptor proteins appear to link large structural proteins during fibre formation, enabling the slime’s remarkable reversibility.

The implications of this discovery are profound. Traditional plastics and synthetic fibres require energy-intensive processes to manufacture and recycle, often involving heat or chemical treatments. In contrast, the velvet worm uses simple mechanical forces – pulling and stretching – to generate strong, durable fibres from biorenewable precursors, which can later be dissolved and reused without harmful byproducts.

While a plastic bottle that dissolves in water may seem like an impractical solution, Harrington believes that adjusting the chemistry of this binding mechanism could overcome this limitation. The team’s next challenge will be to experimentally verify the binding interactions and explore whether the principle can be adapted for engineered materials.

The study was co-authored by researchers from McGill University and Nanyang Technological University (NTU) in Singapore, highlighting the importance of international collaboration in addressing pressing global challenges.

As Harrington aptly puts it, “Nature has already figured out a way to make materials that are both strong and recyclable. By decoding the molecular structure of velvet worm slime, we’re now one step closer to replicating that efficiency for the materials we use every day.”

Continue Reading

Trending